Search this website
Home
Tumour Sites
Sub Groups or Cross Cutting Groups
Terms of Reference
Tumour Site Specific Information
Medicines & Prescribing
Governance & SOPs
Network Chemotherapy Prescription Proformas/Protocols (NHS Staff use)
Additional Prescribing Documents
SACT Pathways
Guidelines for the Management of SACT Induced Adverse Reactions
ICI Immunotherapy
Nursing
Oncological Treatment Guidelines
E Prescribing Documents
Patients, Carers and Community
NHS Hospital Cancer Services
Hospice Information
Information and Resources
About us
Kent & Medway Cancer Collaborative (KMCC) team
Lung - SCLC
MULTI-018 Larotrectinib v2
MULTI-019 Entrectinib v2
LUN-041 Atezolizumab (sc), carboplatin and etoposide for SCLC v4
